Target Price Playground
GSK
$47.76
Swing & Horizon Engine
Need pre-expiry P&L (+3d / +5d), multi-leg ratios, or hedged overlays on GSK? Launch with your exact active legs & +20.0% target.
Forward Projection
If price hits $57 by Jan 15
Multi-Option Simulator
Pre-expiry +3d/+5d & Overlays
Options Architect
Multi-leg solver & Greeks
1x1x1 Structure
Reverse Time-Diagonal + Call
๐ Strategy
Long Stock
Long Call
Long Put
Bull Call Spread
Bear Put Spread
Bear Call Credit Spread
Bull Put Credit Spread
Covered Call
Protective Put
Cash-Secured Put
Diagonal Put Spread
Long Straddle
Bet on big move in either direction. Two premiums paid.
๐ฏ Target
1-Click Institutional Target Anchors:
56d from today
โ๏ธ Legs
LONG CALL ยท $48 ยท Jan '27
Qty 1 ยท Premium $2.28 ยท ฮ 0.53
LONG PUT ยท $48 ยท Jan '27
Qty 1 ยท Premium $2.19 ยท ฮ -0.47
P&L at Expiry
Stock (100 sh)
Long Straddle
Now
Target
๐ก Stock vs Options at Target
If GSK hits $57 by Jan 15: the long straddle returns +$484 (108.2%) on $447 risked, vs +$955 (20.0%) for 100 shares on $4,776. Options give 5.4ร capital efficiency.
๐ Expiry & Gamma Wall Alignment
Options expire Jan 15, 2027 (56 days out). P&L shown is the value at expiry if GSK is at $57.
๐ Projected Return
P&L if GSK hits $57 by Jan 15
+$484
+108.2% on $447 risked
Max Profit
Unlimited
Unlimited on a big move
Max Loss
โ$447
Both premiums paid
Break-even
$43.53 / $52.47
Two-sided breakeven range (ยฑ9.86% from spot)
Prob. of Profit at Expiry (PoP)
42.7%
Outside breakeven range ($43.53 โ $52.47)
ยท Touch Target: 9%
30-Day Theta Burn (If Flat)
โ$119
26.6% of entry cost ยท Daily ฮ: $-3.97/day
Net ฮ / ฮ / V
5.97 / -3.97 / 14.88
per spread, per $1 move / day / vol pt
๐ P&L Scenarios โ what happens at different prices and dates
| GSK Price | Today | +3d (Nov 23) | +7d (Nov 27) | Dec 8 | Dec 27 | Jan 15 (exp) |
|---|---|---|---|---|---|---|
| $38 (-20%) | +$511 | +$510 | +$511 | +$513 | +$521 | +$532 |
| $41 (-15%) | +$301 | +$298 | +$294 | +$287 | +$283 | +$293 |
| $43 (-10%) | +$132 | +$126 | +$117 | +$94 | +$59 | +$55 |
| $45 (-5%) | +$27 | +$17 | +$3 | -$38 | -$117 | -$184 |
| $47 (-2%) | +$1 | -$11 | -$27 | -$74 | -$174 | -$327 |
| $48 (0%) โ spot | -$0 | -$12 | -$29 | -$78 | -$186 | -$423 |
| $49 (+2%) | +$12 | -$0 | -$17 | -$67 | -$175 | -$375 |
| $50 (+5%) | +$53 | +$41 | +$25 | -$23 | -$121 | -$232 |
| $53 (+10%) | +$174 | +$164 | +$151 | +$113 | +$46 | +$7 |
| $55 (+15%) | +$345 | +$337 | +$327 | +$301 | +$262 | +$245 |
| $57 (+20%) โ target | +$548 | +$542 | +$536 | +$518 | +$496 | +$484 |
Uses GSK's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.